by Prof David J.R. Foster PhD | Jun 28, 2022 | Uncategorized
Population pharmacokinetics and pharmacodynamics of the therapeutic and adverse effects of ketamine in patients with treatment-refractory depression Presented on Tuesday, 28 June 2022 | 10:00pm (UK time)| 5:00pm (NYC time) | Wednesday, 29 June 2022, 6:30am (Adelaide,...
by Radhika Rawat, MD, PhD | Jun 14, 2022 | Uncategorized
Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice Presented on Tuesday 14th June 2022 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Radhika Rawat, Elif Tunc-Ozcan, Tammy L. McGuire,...
by Sara de la Salle, PhD | May 24, 2022 | Uncategorized
Electrophysiological correlates and predictors of the antidepressant response to repeated ketamine infusions in treatment-resistant depression Presented on Tuesday 24th May 2022 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Sara de la Salle,...
by David Samuel Mathai, MD | May 10, 2022 | Uncategorized
Toward Synergies of Ketamine and Psychotherapy Presented on Tuesday 10th May 2022 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) David S Mathai, Victoria Mora, Albert Garcia-Romeu. Front Psychol. 2022 Mar 25;13:868103. doi:...
by Vasileia Kotoula, PhD | Mar 22, 2022 | Uncategorized
Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission From Depression Presented on Tuesday 22nd March 2022 | 04:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Vasileia Kotoula, Argyris Stringaris, Nuria...
by Pamela Kryskow, MD | Feb 22, 2022 | Uncategorized
A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression Presented on Tuesday 22nd February 2022 | 5.30 PM (UK time) | 12:30 PM (EDT NY time) | 9.30 AM (PDT LA...
